CURRENT STATUS OF THROMBOLYTIC THERAPY.
D000906:Antibodies; D003850:Deoxyribonuclease I; D004358:Drug Therapy; D005337:Fibrin; D005340:Fibrinogen; D005341:Fibrinolysin; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders; D009525:Niacin; D010827:Physiology; D010958:Plasminogen; D011749:Pyrogens; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D015912:Thrombolytic Therapy; D013927:Thrombosis; D014116:Toxicology
D000906:Antibodies; D011749:Pyrogens; D009525:Niacin; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin
ANTIBODIES; DRUG THERAPY; FIBRIN; FIBRINOGEN; FIBRINOLYSIN; FIBRINOLYSIS; HEMORRHAGIC DIATHESIS; NICOTINIC ACID; PHYSIOLOGY; PLASMINOGEN; PYROGENS; STREPTODORNASE AND STREPTOKINASE; THROMBOSIS; TOXICOLOGIC REPORT